Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development

Intravenous heroin use in Haiphong, Vietnam: Need for comprehensive care including methamphetamine use-related interventions

“…Widening treatment options or allowing easier and more flexible methadone issue could facilitate access to new patients, while enabling individualization of the treatment and job rehabilitation for those already stabilized under methadone treatment. But many obstacles still have to be faced (Carrieri et al, 2014; Hammett et al, 2014; Ma et al, 2016; Matheson et al, 2016). …”

What is known about community pharmacy supply of naloxone? A scoping review

“…Method for payment unclear, and may not translate to community pharmacy setting Examples of patient group directions exist in the NHS in the UK Matheson, et al, 2015). These models involve pharmacist supply, though they are usually operating within health services as opposed to community pharmacy.…”

“…Levels of engagement with harm reduction more broadly vary between the US, Australia, Europe and the United Kingdom (UK), with supervised dosing of opioid substitution treatments for example not being common practice in the US, in contrast with being an accepted practice model in Australia (Green, Dauria, Bratberg, Davis, & Walley, 2015;Watson & Hughes, 2012). Analyses of changing attitudes over time demonstrate that in Scotland, pharmacists have demonstrated a willingness to receive further training, which in turn appears to increase their participation in harm reduction activities (Matheson, Thiruvothiyur, Robertson, & Bond, 2015).…”

Public attitudes and beliefs about Virginia community pharmacists dispensing and administering naloxone

“…[11][12][13][14][15][16][17][18] However, research has also suggested that education can help to combat these barriers, and studies have associated naloxone availability with a decrease in drug misuse. [19][20][21][22][23] The significant role of the community pharmacist in expanding access to naloxone and educating the public has been examined and established in several studies. 19,20,24,25 In addition, studies have examined provider and pharmacist attitudes toward dispensing naloxone and its availability, but none has focused specifically on the public's attitudes toward naloxone dispensing by community pharmacists.…”

“…19,20,24,25 In addition, studies have examined provider and pharmacist attitudes toward dispensing naloxone and its availability, but none has focused specifically on the public's attitudes toward naloxone dispensing by community pharmacists. 12,14,15,[20][21][22] To our knowledge, this was the first study focusing specifically on public attitudes and beliefs concerning community pharmacists dispensing and administering naloxone at the time of the study design. Since then, there has been 1 study published examining consumer and pharmacist attitudes on pharmacy-based naloxone in Massachusetts and Rhode Island.…”